Estradiol Film, Extended Release
Product Images NDC 50090-7610

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Estradiol (NDC 50090-7610). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Estradiol Figure 1)

Chemical structure of estradiol, showing the steroid backbone with hydroxyl groups and a methyl group attached. The diagram depicts the molecular arrangement of this active hormone ingredient.*

FDA Label Image

Figure D (Estradiol Figure 10)

An instructional illustration showing two hands peeling apart a section of a transdermal film or patch, likely depicting how to open or separate the protective backing from the extended-release estradiol film.*

FDA Label Image

Figure E, F (Estradiol Figure 11)

Two black-and-white instructional illustrations labeled Figure E and Figure F showing application sites for a transdermal Estradiol extended release film. The images depict a person placing the film on the lower abdomen area, with Figure E showing the left side and Figure F showing the right side of the lower abdomen near the hip.*

FDA Label Image

Figure G (Estradiol Figure 12)

An instructional illustration showing the application of a transdermal estradiol film. The image depicts hands pressing the film onto the skin, highlighting the correct placement and adhesion method for the extended-release dosage form.*

FDA Label Image

Layers (Estradiol Figure 2)

An instructional diagram showing the three-layer construction of an estradiol transdermal film. The layers are labeled as (1) Backing, (2) Adhesive containing estradiol, and (3) Protective liner.*

FDA Label Image

Figure1 (Estradiol Figure 3)

A pharmacokinetic line graph showing serum estradiol concentration (pg/mL) over time (days) for three different dosing regimens of estradiol: 0.1 mg/day, 0.05 mg/day, and 0.025 mg/day. The graph depicts concentration increases shortly after dosing, plateaus, and gradual decreases over a 5-day period.*

FDA Label Image

Figure2 (Estradiol Figure 4)

A bar chart comparing mean reduction from baseline in an unspecified measure at weeks 4, 8, and 12 between Vivelle 0.0375 mg/day (Estradiol) and placebo groups. Bars show greater reduction with Vivelle at each time point, with sample sizes and standard deviations noted. Statistically significant differences are indicated between Vivelle and placebo.*

FDA Label Image

Figure3 (Estradiol Figure 5)

A line graph showing percentage change from baseline over treatment duration at Weeks 26, 52, 78, and 104. It compares five groups including Vivelle at doses 0.1 mg/day, 0.05 mg/day, 0.0375 mg/day, 0.025 mg/day, and a placebo group. The y-axis represents % change from baseline, and the x-axis shows treatment duration in weeks.*

FDA Label Image

Figure4 (Estradiol Figure 6)

Line graph depicting percentage change from baseline over treatment duration (weeks 26, 52, 78, 104) for different dosages of Vivelle (0.1, 0.05, 0.0375, 0.025 mg/day) and placebo in a transdermal estradiol study. The graph shows trends comparing multiple dosage groups to placebo with statistical significance noted.*

FDA Label Image

Figure A (Estradiol Figure 7)

An instructional illustration depicting the Estradiol Transdermal System by A-S Medication Solutions. The diagram shows a carton, an open calendar-style dispensing box with labeled compartments, and a pouch containing the transdermal patch, highlighting the packaging and delivery format of the 0.0375 mg/d extended-release estradiol film.*

FDA Label Image

Figure B (Estradiol Figure 8)

An instructional illustration showing a hand writing on a medication guide or patient information leaflet titled "Estradiol Transdermal System." The leaflet appears to contain usage instructions and a reminder to document the medication schedule.*

FDA Label Image

Figure C (Estradiol Figure 9)

An instructional illustration showing hands opening a foil pouch containing an Estradiol extended-release transdermal film. The pouch is being torn open at the edge to access the film inside. The image depicts the proper way to open the packaging before applying the medication.*

FDA Label Image

Label Image (Lbl500907610)

Label for Estradiol transdermal system film, extended release, 0.0375 mg/day, by A-S Medication Solutions. The label includes product and lot numbers, strength, dosage information, storage instructions to keep between 68 to 77 degrees F and avoid freezing, and indicates the package contains 8 systems. The package is distributed by A-S Medication Solutions, Libertyville, Illinois.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.